Biosensors in Clinical Trials: More from John Lowry in Ireland

I blogged a few weeks ago about the potential of biosensors to be used to monitor neurochemical brain activities in clinical trial patients in real time, from the work of Irish researcher John Lowry. Yesterday, I spoke with Lowry to dig further into why companies like Lilly are interested in his technology, and what obstacles exist before biosensors might be used in human trial subjects. Here is the summary of that interview.

--Paul Thomas

Real-Time Neurochemical Monitoring of Trial Patients?

A good article in the Irish Times detailing some of the work in the Emerald Isle to speed drug development. The lead is about the work of John Lowry at the National University of Ireland Maynooth. Some of Lowry's research is available online. Here is a journal article detailing his team's efforts to enhance the selectivity of its biosensors. And here is a thorough video on Lowry and his biosensor work.

--Paul Thomas